The role of antibiotics and probiotics in pouchitis

Annals of Gastroenterology

Volumn 25, Issue 2, 2012, Pages 100-105

  Gionchetti, Paolo ^a   Calafiore, Andrea ^a   Riso, Donatella ^a   Liguori, Giuseppina ^a   Calabrese, Carlo ^a   Vitali, Giulia ^b   Laureti, Silvio ^b   Poggioli, Gilberto ^b   Campieri, Massimo ^a   Rizzello, Fernando ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antibiotics; IBD; Pouchitis; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BUDESONIDE; CIPROFLOXACIN; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOGLOBULIN A; INTERLEUKIN 10; LACTOBACILLUS RHAMNOSUS EXTRACT; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; PLACEBO; PROBIOTIC AGENT; RIFAXIMIN; TINIDAZOLE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VSL3;

ABDOMINAL DISCOMFORT; ANTIBACTERIAL ACTIVITY; BIFIDOBACTERIUM; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; ESCHERICHIA COLI; FOLLOW UP; GASTROINTESTINAL MUCOSA; HEADACHE; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; ILEUM RESECTION; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; NAUSEA AND VOMITING; NUTRITIONAL HEALTH; OPEN STUDY; PATHOGENESIS; PATIENT COMPLIANCE; PATIENT REFERRAL; PERMEABILITY BARRIER; PROCTOCOLECTOMY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RELAPSE; REMISSION; REVIEW; SACCHAROMYCES BOULARDII; STREPTOCOCCUS; STREPTOCOCCUS THERMOPHILUS; TASTE DISORDER; TREATMENT OUTCOME; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

EID: 84859865124     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Guarner F, Casellas F, Borruel N, et al. Role of microecology in chronic inflammatory bowel diseases. Eur J Clin Nutr 2002;56:S34-S38.
2. Neut C, Bulois P, Desreumaux P, et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol 2002;97:939-946.
3. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006;55:205-211.
4. Sokol H, Seksik P, Furet JP, et al. Low counts of fecalibacterium pausnitzii in colitis microbiota. Inflamm Bowel Dis 2009;15:1183-1189.
5. Sokol H, Pigneur B, Watterlot L, et al. Fecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn' disease patients. PNAS 2008;105:16731-16736.
6. Duchmann R, Kaiser I, Hermann E, et al. Tolerance exist towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995;102:445-447.
7. Janowitz HD, Croen EC, Sachar DB. The role of the faecal stream in Crohn's disease: an historical and analytic perspective. Inflamm Bowel Dis 1998;4:29-39.
8. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:771-774.
9. Abdelrazeq AS, Kandiyil N, Botterill ID, et al. Predictors for acute and chronic pouchitis following restoration proctocolectomy for ulcerative colitis. Colorectal Dis 2007;10:805-813.
10. Sartor RB. Insights into the pathogenesis of inflammatory bowel disease provided by new rodent models of spontaneous colitis. Inflamm Bowel Dis 1995;1:64-75.
11. Campieri M, Gionchetti P. Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? Gastroenterology 1999;116:1246-1249.
12. Metchnikoff E. The Prolongation of Life: Optimistic Studies. William Heinemann: London; 1907, pp. 161-183.
13. Schaafsma G. State of the art concerning probiotic strains in milk products. IDF Nutr Newsl 1996;5:23-24.
14. Lee YK, Salminen S. The coming age of probiotics. Trends Food Sci Technol 1995;6:241-245.
15. Ng SC, Hart AL, Kamm MA, et al. Mechanism of action of probiotics: recent advances. Inflamm Bowel Dis 2009;15:300-310.
16. Pardi DS, D'Haens G, Shen B, Campbell S, Gionchetti P. Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis 2009;15:1424-1431.
17. Ruseler-van-Embden JGH, Schouten WR, van Lieshout LMC. Pouchitis: result of microbial imbalance? Gut 1994;35:658-664.
18. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:305-309.
19. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy for maintaining remission in recurrent or refractory pouchitis. Gut 2004;53:108-114.
20. Ulisse S, Gionchetti P, D'Alò S, et al. Increased expression of cytokines, inducible nitric oxide synthase and matrix metalloproteinases in pouchitis: effects of probiotic treatment (VSL#3). Gastroenterology 2001;96:2691-2699.
21. Kuisma J, Mentula S, Kahri A, et al. Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 2003;17:509-515.
22. Shen B, Brzezinski A, Fazio VW, et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther 2005;22:721-728.
23. Gionchetti P, Rizzello F, Helvig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind placebo controlled trial. Gastroenterology 2003;124:1202-1209.
24. Gionchetti P, Rizzello F, Morselli C, et al. High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum 2007;50:2075-2082.
25. Biancone L, Michetti P, Travis S, et al. European evidence-based Consensus in the management of ulcerative colitis: special situations. J Crohns Colitis 2008;2:63-92.
26. Sandborn WJ, Mc Leod, Jewell DP. Medical therapy for induction and maintenance of remission in pouchitis. A systematic review. Inflamm Bowel Dis 1999;5:33-39.
27. Hurst RD, Molinari M, Chung P, Rubin M, Michelassi F. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996;131:497-502.
28. Madden M, McIntyre A, Nicholls RJ. Double-blind cross-over trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994;39:1193-1196.
29. Shen B, Achkar JP, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001;7:301-305.
30. Gionchetti P, Rizzello F, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999;13:713-718.
31. Mimura T, Rizzello F, Helwig U, et al. Four week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002;16:909-917.
32. Shen B, Fazio VW, Remzi FH, et al. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis Colon Rectum 2007;50:498-508.